Schistosoma mansoni: immunity in Macaca mulatta.
D000818:Animals; D000917:Antibody Formation; D000961:Antilymphocyte Serum / Q000494:pharmacology; D003168:Complement Fixation Tests; D003520:Cyclophosphamide / Q000494:pharmacology; D005428:Flocculation Tests; D000882:Haplorhini / Q000276:immunology*; D006386:Hemagglutination Tests; D007110:Immunity, Active; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000494:pharmacology; D007814:Larva / Q000187:drug effects / Q000254:growth & development; D008251:Macaca; D010270:Parasite Egg Count; D010323:Passive Cutaneous Anaphylaxis; D010406:Penicillins / Q000494:pharmacology; D011233:Precipitin Tests; D011830:Radiation Effects; D012550:Schistosoma mansoni / Q000187:drug effects / Q000254:growth & development / Q000276:immunology* / Q000528:radiation effects; D012552:Schistosomiasis / Q000276:immunology*; D012882:Skin Tests; D013307:Streptomycin / Q000494:pharmacology
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D010406:Penicillins; D003520:Cyclophosphamide; D013307:Streptomycin